CD276 and nonpapillary renal cell carcinoma: Therefore, we can conclude thatknocking down CD276 significantly inhibits the FAK-MAPK pathway in ccRCC cellmodels, which is likely another mechanism by which knocking down CD276 enhances thesensitivity to sunitinib.